Breaking News, Promotions & Moves

Inozyme Pharma Appoints SVP, Regulatory Affairs

Dr. Kevin B. Johnson brings over 25 years of experience to the role.

By: Contract Pharma

Contract Pharma Staff

Inozyme Pharma Inc. has appointed Kevin B. Johnson, Ph.D., MBA, as senior vice president, regulatory affairs, effective immediately.   Johnson brings more than 25 years of experience in developing and implementing global regulatory and clinical development strategies for rare diseases across entire product development lifecycles from preclinical through clinical development and ultimately to product approval for a variety of drugs, biologics, combination products and cell/gene therapies. He will...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters